Brought to you by 
Series A financing grosses €8.5mm for Affiris
13 Apr 2006
Executive Summary
Austrian vaccine developer Affiris GMBH raised €8.5mm ($10.4mm) in a Series A financing to sole investor MIG Funds, which will split the milestone-based investment among three funds.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A financing grosses €8.5mm for Affiris
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice